Class VI

Olubunmi Akinbajo, MD

Olubunmi Akinbajo, MD is a board-certified anesthesiologist, interventional pain management physician, and emerging healthcare investor with more than 15 years of clinical experience across leading academic and community health systems in the Northeast US. At Nuvance Health Network, he served as Departmental Lead for Patient Safety, driving quality improvement and institutional policy reform. His investment focus spans AI-driven healthcare transformation, virtual care platforms, and clinical decision support systems: areas where he believes the most transformative innovations emerge when medicine and capital work in tandem. He holds an MD from Icahn School of Medicine at Mt. Sinai, MBA from Cornell University’s Johnson Graduate School of Management and an MS in Health Policy and Healthcare Leadership from Weill Cornell Graduate School of Medical Sciences.

Brittany Austin

Brittany Austin is a strategy executive with a track record spanning corporate development, M&A, enterprise technology partnerships, and investment-adjacent strategic initiatives at some of the world’s most influential financial and technology companies. As Vice President of Strategy & Partnerships at Citibank, she leads digital wallet growth, e-commerce strategy, and emerging agentic commerce initiatives. Prior to Citi, Brittany held Strategy, Corporate Development, and M&A roles at Meta, American Express, and Moody’s, including work on multi-billion-dollar acquisitions, post-acquisition value creation, and cross-functional transformation programs that shaped how large organizations deploy capital for long-term growth. She holds an MBA from The Wharton School with concentrations in Finance and Strategic Management and a B.A. in Science and Technology Studies from Cornell University. Brittany is expanding her focus across AI, digital platforms, and transformative technologies, with particular interest in the evolving intersection of commerce, consumer behavior, and emerging technology.

Arundhati Biswas, MBBS

Arundhati Biswas, MBBS, is a board-certified neurosurgeon and endovascular specialist with more than a decade of attending-level experience across brain, spine, trauma, tumor, and cerebrovascular care. Having trained and practiced across India, Canada, and the United States, she brings a cross-system perspective on where innovation meets and misses real-world clinical adoption. Arundhati is now translating her frontline surgical expertise into venture, with a focus on AI-driven physician workflow tools, preventable error reduction, and scalable healthcare solutions for varied resource settings. She received her MBBS from GS Medical College & KEM Hospital, Mumbai; completed her neurosurgery residency at Albert Einstein College of Medicine; and her postdoctoral fellowship at McGill University.

Yohann Braizat

Yohann Braizat is a venture operator and investor with a background spanning institutional finance, capital markets, and early-stage venture. As Venture Manager at Creative Destruction Lab Montréal, he works with founders, investors, and scientists to assess venture readiness, sequence commercial objectives, and de-risk key milestones across AI, supply chain, and Web3. Before CDL, Yohann advised institutional investors on fixed-income strategies at AFS Group in the Netherlands, led cross-border transformation for private and investment banks at Capco across Europe, and contributed to the international growth of DEGIRO, a European fintech platform acquired for €250 million. He targets early-stage ventures in complex, regulated markets where risk sequencing determines what scales. Yohann holds an MBA from Excelia Business School and a Bachelor’s in Foreign Languages Applied to Economics from Université de Lorraine.

Kendrick Carson

Kendrick Carson is a sales leader and emerging investor with more than a decade of experience scaling technical infrastructure across startups and Global 2000 enterprises. At Google Cloud, he partners with the startup acquisition team to assess technical scalability and provide infrastructure support for early-stage companies. His prior roles at Oracle, Sumo Logic, and EnterpriseDB, where he built strategic partnerships with AWS, Adobe, and Disney and grew sales territories 2-3x, gave him a deep technical lens for evaluating competitive moats, product defensibility, and data-backed growth. That fluency in cloud infrastructure, DevOps, and data analytics translates directly into how he evaluates early-stage companies: identifying durable technical advantages before they become obvious to the market and understanding what it takes to scale. Kendrick holds a BS in Journalism from California Polytechnic State University.

Tom Darlington, PhD

Tom Darlington, PhD is a scientist, operator, and investor focused on diagnostics, women’s health, and infectious disease. He directs investment at BVD Healthcare, a family-backed strategic fund in life sciences, diagnostics, and medical devices, and advises investors and operators through his consultancy, Blue Tide Bio. At nanoComposix, Tom built the operations, manufacturing, and quality systems that scaled the company from a garage startup to its 2021 acquisition by Fortis Life Sciences as a nanomaterial CDMO and diagnostics developer. His doctoral research at Scripps Research first closed the molecular feedback loop of the circadian clock: a milestone discovery featured in the official Scientific Background for the 2017 Nobel Prize in Physiology or Medicine. Tom holds a PhD in Macromolecular and Cellular Structure and Chemistry from Scripps Research and a BA in Chemistry and Economics from Duke University.

Sujan Gogu, DO

Sujan Gogu, DO is a triple board-certified physician in family medicine, sports medicine, and pain medicine who brings deep clinical expertise to healthcare innovation through his investing. As a physician in the US Olympic & Paralympic Committee Sports Medicine Volunteer Program, he has supported Team USA athletes through USA Boxing and USA Badminton as well as serving as team physician for the NBA G-League Rio Grande Valley Vipers. A published voice on healthcare access and physician-led reform, his investments focus on healthcare innovations where his clinical experience in sports medicine, musculoskeletal care, and pain medicine gives him a differentiated lens. Sujan holds a DO from Edward Via College of Osteopathic Medicine and a BS in Biology from the University of Texas at San Antonio.

Sarah Hack

Sarah Hack is a media executive, attorney, and investor with a career spanning film, television, and digital audio at some of the most influential companies in entertainment. She began her career with Mark Cuban and Todd Wagner’s media companies, holding production, sales, and legal roles across Magnolia Pictures, HDNet Films, and Landmark Theatres before leading Business Affairs at Walt Disney-ABC TV and Radical Media. In audio, Sarah served as a senior leader at Lemonada Media, a high-growth VC-backed podcast company, where she oversaw business and legal affairs for marquee shows including Wiser Than Me with Julia Louis-Dreyfus and multiple #1 Apple and Spotify titles. She is co-founder of MOSH Audio and runs a consulting practice serving film, TV, podcast, and nonprofit clients. Sarah holds a BA from Williams College and a JD from Cornell University.

Emily Latour

Emily Latour is a venture strategist, growth advisor, and founder with more than 20 years of experience accelerating companies across enterprise, mid-market, and venture capital ecosystems. As Founder and CEO of Latour Advisory, she partners with early-stage founders, venture capital firms, and family offices, most recently leading a $100M acquisition of a patented medical device and associated manufacturing technology. Previously as Managing Partner at Gartner, Emily led a $15M+ private equity and high-tech P&L, guiding portfolio companies in reducing risk and scaling sustainably to realize capital-efficient growth. Prior to that, she held senior executive roles at Accenture, where she helped digital native and traditional organizations accelerate new products from zero to $1B. Emily holds a BA in Business Management from Southwestern University.

Jenifer Lee

Jenifer Lee is a biopharma executive, venture partner, and investor with more than two decades of experience advancing novel therapies through clinical development and commercialization. She has contributed to the approval of nine novel therapies, including Xtandi and ORSERDU, representing more than $20 billion in value creation. As a Venture Partner at Cancer Fund and board director of Enzyme by Design, Jenifer focuses on life sciences innovation, execution risk, and responsible company building. She currently serves as EVP overseeing global portfolio management, clinical operations, regulatory execution, and AI-enabled data governance at a clinical-stage biotechnology company, with a record of zero major FDA inspection findings across her career. Jenifer holds an MS in Clinical Research and Regulatory Administration from Northwestern University and a BS in Biochemistry from the University of Illinois at Chicago.

Debon Lewis

Debon Lewis is an investor, entrepreneur, and executive advisor whose work bridges capital formation, leadership development, and social impact. As co-Founder and General Partner of Sankofa Family Ventures, he channels investment capital into diverse fund managers to bridge the values-alignment gap and build generational wealth. Debon is also co-founder of AKALA, a Google-backed edtech company in the college guidance and access space, and founder of Transformative Growth Partners, a leadership development consultancy across industries through a DE&I and emotional intelligence lens. Earlier, he was the founding Principal of Achievement First Bridgeport Academy Middle School, now ranked the #2 charter middle school in Connecticut. Debon holds a BA in Political Science and Africana Studies from the University of Pennsylvania and a Master’s in Educational Leadership from National Louis University.

Edo Mwenda, PhD

Edo Mwenda, PhD is a technology commercialization professional, synthetic organic chemist, two-time founder, and investor with a career spanning IP strategy, licensing transactions, and venture creation. At the Office of Innovation and New Ventures at Seattle Children’s Research Institute, he structures and closes licensing deals across infectious disease, gene therapy, and metabolic disease, including an exclusive license for an AI platform predicting CAR-T toxicity and a technology license for an AAV gene therapy targeting epilepsy. Previously, Edo prosecuted 15+ patent applications before the USPTO, conducting technical due diligence on portfolios for clients that completed an IPO and a major pharmaceutical acquisition. He co-founded QCMedchain, a blockchain pharmaceutical supply chain startup. An AUTM Technology Transfer Fellow, Edo holds a PhD in Organic Chemistry from the University of Iowa and a BA in Chemistry from Macalester College.

Sheila Nabanja, PhD

Sheila Nabanja, PhD is a deep-tech operator and emerging early-stage investor with a decade of experience building safety-critical hardware and ML-enabled systems at Apple and Cruise. She contributed to Vision Pro and Project Titan at Apple and led multi-camera architecture for autonomous vehicle perception at Cruise. Sheila’s investing focus is across AI-enabled infrastructure, mobility, climate, and global education, with particular interest in founders building for underserved markets. She specializes in translating deep technical complexity into high-stakes product and investment decisions, bringing rare diligence to frontier ventures at the seed and early stages. Sheila serves as Executive Director of Musizi University Foundation, where she is leading the launch of Musizi University, and serves on the boards of Impact Water Foundation, Musizi University Foundation, and the finance committee of Ashesi University Foundation. Sheila holds a PhD in Electrical Engineering from MIT.

Hope Neighbor

Hope Neighbor is a mission-driven executive, impact investor, and innovator with two decades of experience mobilizing philanthropic, public, and private capital to address social and health inequality. She currently leads population health management within CalAIM, California’s transformation of its Medicaid system, and serves as Executive Sponsor of Medi-Cal Connect, a first-in-the-nation statewide population health platform. Previously, Hope co-founded Camber Collective, served as CEO of Rhia Ventures and its $40M impact fund, and advised early-stage health equity and technology-enabled care management organizations. Her work has unlocked hundreds of millions of dollars for impact across population health, women’s health, economic opportunity, and financial inclusion in the US, Africa, Europe, and South Asia. Hope holds an MPA in Development Studies from Princeton University and a BA in Public Policy from Pomona College.

Laurel Nelson

Laurel Nelson is a life sciences and diagnostics executive and healthcare investor with nearly two decades of leadership spanning molecular diagnostics, oncology, immunology, and precision medicine. She has led go-to-market strategy, product launches, and business development across diagnostics and biotech, with deep expertise in liquid biopsy, transplant diagnostics, and women’s health. She invests in early-stage healthcare and medtech innovations, and she brings scientific fluency and commercial execution to help founders bridge the gap between innovation and the market. Her experience across PE-backed companies and public company M&A gives her direct expertise in identifying scientific innovation with commercial viability. Laurel holds an MBA in International Marketing from Saint Mary’s College of California.

Asad Rahman

Asad Rahman is an impact investor and venture builder with a decade of experience deploying capital to early-stage health and education ventures across sub-Saharan Africa and South Asia. As Practice Lead for Venturing at Brink, he channels non-dilutive funding toward ideas with the potential to be absorbed into public systems infrastructure: supporting innovations ranging from drone delivery of health supplies in Malawi to personalized learning software in Kenya to prosthetics designed for low-resource settings in Sierra Leone. His work spans both for-profit and nonprofit organizations navigating the intersection of capital and systemic change. Asad holds an MSc in International Public Policy from University College London.

Heather Rebuelta

Heather Rebuelta is an angel investor and operator with experience spanning venture finance, early-stage investing, and growth equity. Her investing career includes roles at Silicon Valley Bank, Motorola Ventures, and Kayne Anderson, supporting companies that went on to achieve $3.7B in combined value across six exits, including three IPOs. Heather’s operating experience includes leading business development and partnerships at Adobe and Logitech, and co-founding an ecommerce brand. She currently invests in early-stage technology companies improving well-being, health, and productivity, and supports digital health innovators at UCSF Innovation Ventures’ Catalyst Program and underrepresented entrepreneurs at ICA Fund. Heather holds an MBA from the University of Chicago Booth School of Business and a BA in Business Economics from UCLA.

Manoj Reddy, MD

Manoj Reddy, MD is a board-certified radiation oncologist, founder, and emerging investor whose work spans the full cancer continuum from advanced treatment to survivorship, metabolic health, and whole-person care. He founded the Integrative Oncology Working Group (IOWG) in 2020, which has grown into a global clinician community of more than 3,000 oncology professionals across 78 countries, hosting 85+ expert-led sessions on oncology, lifestyle medicine, AI, and emerging health technologies. With fellowship training in integrative medicine, board certification in obesity medicine, and an AI certificate from MIT, Manoj brings a uniquely multidisciplinary lens to healthcare innovation. His investment focus brings together medicine, technology, and capital, backing solutions that bring clinical rigor to survivorship, digital health, and whole-person cancer care. Manoj received his MD from Baylor College of Medicine.

Josiah Robinson

Josiah Robinson is an attorney, educator, and emerging investor focused on capital access, policy, and systemic change for historically marginalized communities. As founder of Lobo Consulting and JZR Legal, he advises on innovative solutions to structural inequality, most recently partnering with philanthropic leaders to develop the Hopeful Futures Fund, a trust-based grant fund at Tulsa Community Foundation to support nonprofits catalyzing LGBTQ+ community engagement, leadership development, and economic empowerment and entrepreneurship. A mayoral-appointed City of Tulsa Human Rights Commissioner, Josiah spearheaded the city’s inaugural 2SLGBTQ+ Committee and received a 2025 GLAAD Media Award nomination for Outstanding Print Article. He teaches constructive policymaking at NYU-Tulsa and holds a JD with Honors from Regent University School of Law.

Catherine Tedrow

Catherine Tedrow is a sustainability strategist and climate-focused investor who believes capital is the lever that transforms sustainability from a cost center into long-term value creation. As co-founder of Population, a sustainability consultancy, she builds regenerative business systems for leading brands in the jewelry, fashion, and home industries, developing strategies for responsible sourcing, human rights, and environmental due diligence, sustainable design, and circularity. Catherine’s investment centers on companies embedding climate, circularity, and human rights goals within core operations as drivers of margin resilience and growth. She holds an MBA in Sustainable Business from Bard College.

Mariana Uchoa, PhD

Mariana Uchoa, PhD is a translational immunologist, venture builder, and emerging investor who has spent seven years turning innovative science into clinical programs at venture-backed biotechs in Los Angeles. She has led teams from discovery through first-in-human trials, raised over $20M alongside founders, and built the operational systems that enable fast-moving science. Mariana’s investing interest is in life sciences, community health, and the funding structures that accelerate bold science with a cross-border perspective spanning the US and Brazil. She holds a PhD in Neuroscience from the University of Southern California.

Athena Ullah

Athena Ullah is an infrastructure strategist and investor whose career spans every layer of the built environment, from small business support in Los Angeles to city government, rail operations, and private equity-backed enterprises. Those experiences shaped her belief that capital carries a responsibility to advance the greater good, and that durable progress comes from building thoughtfully on what already exists. Trained at MIT and UC Berkeley, Athena has worked across economic development, transportation, and strategic finance within the engineering and infrastructure sector. Most recently, she served as Vice President at STV, a Pritzker Private Capital portfolio company, where she focused on growth strategy and operational transformation. Athena sees opportunity where technological capability outpaces institutional adoption, backing models that help critical industries evolve faster and more equitably.

María Fernanda Vargas

María Fernanda Vargas is an impact investor and private equity professional with more than 15 years of experience deploying capital across Latin America. She currently leads origination and deployment at Impact Ventures PSM, the impact investing arm of Promotora Social México, where she is deploying a $50M fund focused on social impact investments. Prior to IVPSM, María spent nearly a decade at KM Capital Partners executing M&A transactions, structuring private equity funds, and leading financial restructurings, including infrastructure asset valuations exceeding $250M and a renewable energy PE fund investing in early-stage projects across Mexico. Earlier roles at Avante Capital Privado and FIQUA gave her experience evaluating and promoting startups and growth-stage companies to family offices and institutional investors. María holds a BS in Finance and Public Accounting from Tecnológico de Monterrey.

Tasmin Vosloo

Tasmin Vosloo is a documentary journalist, strategic director, and impact-focused investor whose career spans storytelling, systems change, and philanthropic capital across Africa, Asia, and beyond. As Director of Strategy at the Kym Rapier Foundation, she leads the Foundation’s philanthropic agenda through a systems change lens, designing partnerships that connect capital, creativity, and communities in global developing markets. Her award-winning documentary career includes work with VICE, PBS, and Channel News Asia; Open Secrets won Best Documentary Series at the Asian Academy Awards after reaching tens of millions of viewers worldwide. Tasmin holds a Bachelor of Journalism with Honours from Rhodes University, South Africa, with a triple major in Law, Politics and International Relations, and Journalism.

Paul Williams

Paul Williams is a senior sales executive and investor with a track record of scaling complex commercial organizations across healthcare and technology. As co-Founder and General Partner of Sankofa Family Ventures, he invests in diverse fund managers to build generational wealth. At Amazon Business, Paul leads a $500M channel sales portfolio spanning SaaS providers, wholesale distributors, and cross-border e-commerce platforms, delivering 25% year-over-year revenue growth and a 30% improvement in bottom-line results. Previously, he directed go-to-market strategy across Amazon Business’s $38B US portfolio and spent 18 years at Aetna in progressively senior leadership roles, including managing a $200M international portfolio across the US, Dubai, and the UK. He holds an MBA in Finance from Duke University’s Fuqua School of Business and a BA in Economics from Wesleyan University.

Jenny Yu, MD

Jenny Yu, MD is a healthcare entrepreneur, investor, and advisor bridging clinical medicine, health technology, and venture. As founding partner of Sixth House, a healthcare advisory and venture firm, she invests and advises across the healthcare ecosystem, including VitVio, an AI platform digitizing operating rooms, and Signos, the first OTC FDA-approved AI weight management app. Most recently Jenny served as Chief Medical Officer for RVO Health, a joint venture encompassing Healthline Media, Healthgrades, and Optum Perks. Before that, she spent more than 15 years as a practicing academic surgeon at UPMC, where she expanded rural access to specialists. She is also co-founder of Project Theia, a nonprofit bringing facial reconstructive surgery to underserved communities. Jenny earned her MD from Ohio State University and completed her ophthalmology residency at the University of Pittsburgh School of Medicine.